vismodegib
Showing 26 - 50 of 58
Cancer of Unknown Primary Site Trial in Worldwide (Alectinib, Vismodegib, Ipatasertib)
Active, not recruiting
- Cancer of Unknown Primary Site
- Alectinib
- +17 more
-
Blacktown, New South Wales, Australia
- +140 more
Jan 6, 2023
Extensive Stage Small Cell Lung Carcinoma, Recurrent Small Cell Lung Carcinoma Trial in United States (drug, biological, other)
Completed
- Extensive Stage Small Cell Lung Carcinoma
- Recurrent Small Cell Lung Carcinoma
- Cisplatin
- +4 more
-
Scottsdale, Arizona
- +300 more
Dec 10, 2020
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Prostate Adenocarcinoma, Stage IIA Prostate Cancer AJCC v7, Stage IIB Prostate Cancer AJCC v7 Trial in United States (Goserelin
Terminated
- Prostate Adenocarcinoma
- +2 more
- Goserelin Acetate
- +3 more
-
Ann Arbor, Michigan
- +4 more
Feb 6, 2019
Basal Cell Carcinoma Trial in Tucson (Vismodegib)
Completed
- Basal Cell Carcinoma
- Vismodegib
-
Tucson, ArizonaArizona Cancer Center
Jul 17, 2018
Prostate Cancer Trial in Baltimore (Vismodegib)
Completed
- Prostate Cancer
- Vismodegib
-
Baltimore, MarylandJohns Hopkins Hospital
Oct 5, 2017
Myelofibrosis Trial in Worldwide (Placebo, Ruxolitinib, Vismodegib)
Completed
- Myelofibrosis
- Placebo
- +2 more
-
Fort Myers, Florida
- +12 more
May 4, 2018
Breast Cancer Trial in Pamplona (vismodegib, Paclitaxel, Epirubicin)
Unknown status
- Breast Cancer
- vismodegib
- +3 more
-
Pamplona, Navarra, SpainClĂnica Universidad de Navarra
Oct 23, 2017
Idiopathic Pulmonary Fibrosis Trial in Germany, United States (Pirfenidone, Vismodegib)
Completed
- Idiopathic Pulmonary Fibrosis
- Pirfenidone
- Vismodegib
-
La Jolla, California
- +14 more
Oct 26, 2017
Recurrent Pancreatic Carcinoma, Stage IV Pancreatic Cancer Trial in Ann Arbor (Gemcitabine Hydrochloride, Laboratory Biomarker
Completed
- Recurrent Pancreatic Carcinoma
- Stage IV Pancreatic Cancer
- Gemcitabine Hydrochloride
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Aug 2, 2017
Malignant Tumor Trial in Chicago (Pharmacological Study, Vismodegib)
Completed
- Malignant Neoplasm
- Pharmacological Study
- Vismodegib
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Apr 11, 2017
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Basal Cell Carcinoma Trial in Worldwide (Vismodegib, Placebo)
Completed
- Basal Cell Carcinoma
- Vismodegib
- Placebo
-
Los Angeles, California
- +57 more
Aug 30, 2017
Diffuse Large B-cell Lymphoma, Indolent Non-hodgkin Lymphoma, Primary CNS Lymphoma Trial in France (Vismodegib)
Terminated
- Diffuse Large B-cell Lymphoma
- +3 more
- Vismodegib
-
Creteil, France
- +9 more
Mar 8, 2017
Basal Cell Carcinoma Trial in United States (Placebo, Vismodegib)
Terminated
- Basal Cell Carcinoma
- Placebo
- Vismodegib
-
Scottsdale, Arizona
- +20 more
Mar 27, 2017
Acute Myeloid Leukemia Trial in Montreal (Ribavirin, Vismodegib, Decitabine)
Unknown status
- Acute Myeloid Leukemia
- Ribavirin
- +2 more
-
Montreal, Quebec, CanadaJewish General Hospital
Mar 6, 2017
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (drug, procedure, other)
Completed
- Adult Giant Cell Glioblastoma
- +3 more
- vismodegib
- +3 more
-
Los Angeles, California
- +8 more
Aug 15, 2017
Idiopathic Pulmonary Fibrosis Trial (, vismodegib)
Withdrawn
- Idiopathic Pulmonary Fibrosis
- placebo
- vismodegib
- (no location specified)
Nov 1, 2016
Adult Medulloblastoma Trial in United States (Pharmacological Study, Vismodegib)
Completed
- Adult Medulloblastoma
- Pharmacological Study
- Vismodegib
-
Los Angeles, California
- +12 more
Jan 28, 2016
MDS, Myelogenous Leukemia, Acute Trial in Canada, Germany, United States (cytarabine, vismodegib)
Terminated
- Myelodysplastic Syndromes, Myelogenous Leukemia, Acute
- cytarabine
- vismodegib
-
Stanford, California
- +13 more
Nov 11, 2015
Recurrent Childhood Medulloblastoma Trial in United States (Laboratory Biomarker Analysis, Pharmacological Study, Vismodegib)
Completed
- Recurrent Childhood Medulloblastoma
- Laboratory Biomarker Analysis
- +2 more
-
Los Angeles, California
- +11 more
Dec 10, 2015
Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer Trial in United States
Completed
- Adenocarcinoma of the Gastroesophageal Junction
- +6 more
- oxaliplatin
- +5 more
-
Sacramento, California
- +29 more
Dec 16, 2015